NCT05560646: An ongoing trial by Organon and Co
This trial is ongoing. It must report results 5 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05560646 |
|---|---|
| Title | A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age With Moderate to Severe Endometriosis-related Pain |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 25, 2022 |
| Completion date | May 28, 2025 |
| Required reporting date | May 28, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |